Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Barclays Adjusts Zimmer Biomet Holdings PT to $178 From $186, Maintains Overweight Rating

11/05/2021 | 12:45pm EST


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
01/19Wells Fargo Cuts Zimmer Biomet Holdings to Underweight From Equalweight; Price Target t..
MT
01/11NORTH AMERICAN MORNING BRIEFING : Inflation, Rate -3-
DJ
01/10Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2021 Financial Re..
PR
01/10BTIG Downgrades Zimmer Biomet Holdings to Neutral From Buy
MT
01/10NORTH AMERICAN MORNING BRIEFING : Yields Rise, -3-
DJ
01/07Today on Wall Street: Is it legit?
01/07Morgan Stanley Cuts Zimmer Biomet Holdings to Equalweight From Overweight, Price Target..
MT
01/07ANALYST RECOMMANDATIONS : AT&T, BP Plc, Costco, Lyft, Starbucks...
01/04Today on Wall Street: Plenty of new records
01/04Piper Sandler Downgrades Zimmer Biomet Holdings to Neutral Rating From Overweight, Adju..
MT
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7 870 M - -
Net income 2021 839 M - -
Net Debt 2021 6 461 M - -
P/E ratio 2021 31,4x
Yield 2021 0,78%
Capitalization 25 704 M 25 704 M -
EV / Sales 2021 4,09x
EV / Sales 2022 3,77x
Nbr of Employees 20 000
Free-Float -
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 123,04 $
Average target price 159,00 $
Spread / Average Target 29,2%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-2.97%25 704
ABBOTT LABORATORIES-11.39%213 874
MEDTRONIC PLC2.57%142 671
BECTON, DICKINSON AND COMPANY4.93%75 243
HOYA CORPORATION-10.96%49 292
BAXTER INTERNATIONAL INC.0.17%43 055